Илир Демири

511 total citations
16 papers, 68 citations indexed

About

Илир Демири is a scholar working on Epidemiology, Infectious Diseases and Neurology. According to data from OpenAlex, Илир Демири has authored 16 papers receiving a total of 68 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 6 papers in Infectious Diseases and 5 papers in Neurology. Recurrent topics in Илир Демири's work include COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Илир Демири is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Long-Term Effects of COVID-19 (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Илир Демири collaborates with scholars based in North Macedonia, Austria and Italy. Илир Демири's co-authors include Katerina Spasovska, Mile Bosilkovski, Dragica Zendelovska, Marija Vavlukis, Milena Stevanović, Sanja Petrusevska-Marinkovic, Igor Nikolov, Aleksandar Dimovski, Dimitar G. Efremov and Daniele Focosi and has published in prestigious journals such as Blood, European Heart Journal and Life.

In The Last Decade

Илир Демири

14 papers receiving 66 citations

Peers

Илир Демири
Илир Демири
Citations per year, relative to Илир Демири Илир Демири (= 1×) peers Ayşe Özlem Mete

Countries citing papers authored by Илир Демири

Since Specialization
Citations

This map shows the geographic impact of Илир Демири's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Илир Демири with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Илир Демири more than expected).

Fields of papers citing papers by Илир Демири

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Илир Демири. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Илир Демири. The network helps show where Илир Демири may publish in the future.

Co-authorship network of co-authors of Илир Демири

This figure shows the co-authorship network connecting the top 25 collaborators of Илир Демири. A scholar is included among the top collaborators of Илир Демири based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Илир Демири. Илир Демири is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Демири, Илир, et al.. (2022). Efficacy and Safety of COVID-19 Convalescent Plasma in Hospitalized Patients—An Open-Label Phase II Clinical Trial. Life. 12(10). 1565–1565. 2 indexed citations
2.
Bergami, Maria, Olivia Manfrini, Edina Cenko, et al.. (2022). Prognostic value of brain natriuretic peptide in COVID-19 with or without acute heart failure. European Heart Journal. 43(Supplement_2). 1 indexed citations
3.
Stevanović, Milena, et al.. (2021). COVID-19 PNEUMONIA ASSOCIATED WITH RHABDOMYOLYSIS IN PATIENT WITH PREVIOUS CHRONIC THERAPY WITH STATIN: COINCIDENCE OR REALTED CONDITIONS?. Goce Delchev University Repository (Goce Delčev University of Štip). 4(1). 6–12. 1 indexed citations
4.
Zendelovska, Dragica, et al.. (2021). Evaluation of oxidative stress markers in hospitalized patients with moderate and severe COVID-19. Romanian Journal of Internal Medicine. 59(4). 375–383. 10 indexed citations
5.
Демири, Илир, et al.. (2021). PULMONARY EMBOLISM: A COMPLICATION OF COVID -19 INFECTION IN POSTPARTUM – CASE REPORT. 4(3). 126–130.
6.
Stevanović, Milena, et al.. (2021). Prevalence of Allelic Variants and Clonality of IGHV1-69 Expressing B-Cells in Patients with Different Severity of COVID 19 Disease. Blood. 138(Supplement 1). 994–994. 1 indexed citations
7.
Демири, Илир, et al.. (2021). Insight in the Current Progress in the Largest Clinical Trials for Covid-19 Drug Management (As of January 2021). PRILOZI. 42(1). 5–18. 1 indexed citations
8.
Демири, Илир, et al.. (2020). The Impact of Pneumonia on the Course and Outcome in Patients with Seasonal Influzenza. PRILOZI. 41(2). 63–70. 2 indexed citations
10.
Nikolov, Igor, et al.. (2020). First Experience in Management of Coronavirus Disease 2019 (COVID-19) in Kidney Transplant Patient – Case Report. Open Access Macedonian Journal of Medical Sciences. 8(T1). 240–244.
11.
Демири, Илир, et al.. (2019). Association of Systemic Inflammatory Response Syndrome with Bacteremia in Patients with Sepsis. PRILOZI. 40(2). 51–56. 1 indexed citations
12.
Демири, Илир, et al.. (2018). Epidemiology of Community-Acquired Sepsis in Adult Patients: A Six Year Observational Study. PRILOZI. 39(1). 59–66. 4 indexed citations
13.
Демири, Илир, et al.. (2016). Seasonal Influenza- Factors Associated with a Severe Clinical Form of the Illness. 70(2). 68–74. 1 indexed citations
14.
Демири, Илир, et al.. (2016). Factors Associated with Lethal Outcome in Patients with Severe Form of Influenza. PRILOZI. 37(2-3). 63–72. 4 indexed citations
15.
Демири, Илир, et al.. (2012). Prediction of Outcome from Community-Acquired Severe Sepsis and Septic Shock in Tertiary-Care University Hospital in a Developing Country. Critical Care Research and Practice. 2012. 1–6. 26 indexed citations
16.
Bosilkovski, Mile, et al.. (2012). Doxycycline-rifampin versus doxycycline-rifampin-gentamicin in treatment of human brucellosis. Tropical Doctor. 42(1). 13–17. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026